SLC2A4, solute carrier family 2 member 4, 6517

N. diseases: 158; N. variants: 7
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE Animal studies revealed that VK supplementation dose-dependently upregulated plasma cGas6; stimulated the protein expression of cGas6, PI3K, pAKT, and GLUT4 in skeletal muscle; and reduced hyperglycemia in HFD-fed T2D mice. 31583710 2020
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE Liquorice flavonoid oil suppresses hyperglycaemia accompanied by skeletal muscle myocellular GLUT4 recruitment to the plasma membrane in KK-A<sup>y</sup> mice. 30304967 2019
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 AlteredExpression disease BEFREE Collectively, these data indicate that PNS reduces hyperglycemia and insulin resistance through up-regulating GLUT4 expression and the IRS1-PI3K-AKT signaling pathway. 30945455 2019
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE Here we briefly discussed that wogonin increases Glut4 trafficking to plasma membrane which allows increased entry of glucose and thus alleviates hyperglycemia. 31333118 2019
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 AlteredExpression disease BEFREE Thus, the effects of IOE to ameliorate hyperglycemia and adiposity may be mediated through FGF21 activating insulin signaling and increasing the expression of GLUT4 and pro-thermogenic factors. 31323977 2019
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 AlteredExpression disease BEFREE The MSG administration induced hyperglycemia associated with a decrease in the skeletal muscle glucose transporter 4 (GLUT4) levels and accompanied by deregulation in proteins, G-6Pase, and tyrosine aminotransferase, involved in hepatic glucose metabolism of male and female rats. 30916837 2019
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 AlteredExpression disease BEFREE The role of aqueous-extract of garlic (AEG) and a purified NO-generating protein from garlic (NGPG) was investigated to control hyperglycemia by hepatic insulin synthesis through NGPG induced synthesis of NO via glucose-activated NO-synthase and glucose transporter-4 (Glut-4) in the hepatocytes. 30841444 2019
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE These results suggest that green tea can ameliorate hyperglycemia in diabetic rodents by stimulating GLUT4-mediated glucose uptake in skeletal muscle, and that EGCG is one of the effective compounds that mediate this effect. 31100973 2019
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 AlteredExpression disease BEFREE This phenomenon results in lower redistribution and activation of GLUT4 leading to reduced uptake of D-glucose and hyperglycaemia. 30205799 2019
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE It leads to a reduced uptake of glucose mediated by glucose transporter 4 (GLUT4) in muscle and adipose tissue, and finally hyperglycemia. 30314325 2018
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE Piperine in pepper prevents hyperglycemia by GLUT4 translocation through CaMKKβ/AMPK signaling via TRPV1-dependent increase in the intracellular Ca<sup>2+</sup> level and ROS generation. 29683271 2018
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE In conclusion, these data provide insight that baicalin is a powerful and promising agent for the treament of hyperglycemia via AKT/AS160/GLUT4 and P38MAPK/PGC1α/GLUT4 pathway. 29459024 2018
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 AlteredExpression disease BEFREE Myricitrin administration improved SOD (p < 0.05), CAT (p < 0.01), muscle cell's glycogen content (p < 0.01), Glut-4 gene expression (p < 0.001), Thiazolyl blue tetrazolium bromide (MTT) (p < 0.05), and Bax to Bcl-2 ratio (p < 0.001), and reduced MDA (p < 0.05) compared to hyperglycemia group. 29516429 2018
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 GeneticVariation disease BEFREE Ameliorated TNF-α-induced inflammation and insulin resistance in adipocytes via activation of insulin signaling and enhanced GLUT4 translocation suggesting a reduced hyperglycemia associated with the metabolic syndrome. 28759152 2017
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE [6]-Gingerol, from Zingiber officinale, potentiates GLP-1 mediated glucose-stimulated insulin secretion pathway in pancreatic β-cells and increases RAB8/RAB10-regulated membrane presentation of GLUT4 transporters in skeletal muscle to improve hyperglycemia in Lepr<sup>db/db</sup> type 2 diabetic mice. 28793909 2017
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE Gene expression studies were performed for muscle (GLUT4) and liver tissues (IL6 and PAI1).There was a remarkable decrease in hyperglycemia within two weeks of injection by MetASCs as compared to metformin and ASCs alone. 27842906 2016
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE GLUT4 function is impaired in obesity and type 2 diabetes leading to hyperglycemia and an increased risk of cardiovascular disease and neuropathy. 25596527 2015
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 AlteredExpression disease BEFREE GLUT4 activity is directly correlated with the ability to clear elevated blood glucose and insulin sensitivity. 25215442 2015
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 AlteredExpression disease BEFREE The results strongly suggest that green and black tea suppress high-fat diet-evoked hyperglycemia and insulin resistance by retaining the level of GLUT4 and increasing the level of GLUT4 on the plasma membrane in muscle. 21105694 2010
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE They develop fasting hyperglycemia and glucose intolerance and are at risk for greater insulin resistance than mice lacking GLUT4 in only one tissue. 15578099 2004
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 AlteredExpression disease BEFREE In streptozocin-induced diabetes of the rat with normal fasting insulin levels and marked hyperglycemia, the number of cytochalasin B-binding sites and of GLUT4 proteins diminishes in the PM whereas the GLUT1 proteins increase to a new ratio of about 1.5:1 GLUT4:GLUT1. 1482748 1992